Dequalinium-induced protofibril formation of α-synuclein

Choong Hwan Lee, Jin Kim Hyun, Jung Ho Lee, Hyun Ju Cho, Jongsun Kim, Chul Chung Kwang, Seunho Jung, Seung R. Paik

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

α-Synuclein is the major constituent of Lewy bodies, a pathological signature of Parkinson disease, found in the degenerating dopaminergic neurons of the substantia nigra pars compacta. Amyloidosis generating the insoluble fibrillar protein deposition has been considered to be responsible for the cell death observed in the neurodegenerative disorder. In order to develop a controlling strategy toward the amyloid formation, 1,1′-(1,10-decanediyl)- bis-[4-amino-2-methylquinolinium] (dequalinium), was selected and examined in terms of its specific molecular interaction with α-synuclein. The protein was self-oligomerized by dequalinium, which gave rise to the ladder formation on N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine/SDS-PAGE in the presence of a coupling reagent of N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. The double-headed structure of dequalinium with the two cationic 4-aminoquinaldinium rings was demonstrated to be critical for the protein self-oligomerization. The dequalinium-binding site was located on the acidic C-terminal region of the protein with an approximate dissociation constant of 5.5 μM. The protein self-oligomerization induced by the compound has resulted in the protofibril formation of α-synuclein before it has developed into amyloids. The protofibrils were demonstrated to affect the membrane intactness of liposomes, and they have also been shown to influence cell viability of human neuroblastoma cells. In addition, dequalinium treatment of the α-synuclein- overexpressing cells exerted a significant cell death. Therefore, it is pertinent to consider that dequalinium could be used as amolecular probe to assess toxic mechanisms related to the amyloid formation of α-synuclein. Ultimately, the compound could be employed to develop therapeutic and preventive strategies toward α-synucleinopathies including Parkinson disease.

Original languageEnglish
Pages (from-to)3463-3472
Number of pages10
JournalJournal of Biological Chemistry
Volume281
Issue number6
DOIs
Publication statusPublished - 2006 Feb 10

Fingerprint

Dequalinium
Synucleins
Amyloid
Oligomerization
Cell death
Proteins
Parkinson Disease
Cell Death
Lewy Bodies
Molecular interactions
Poisons
Dopaminergic Neurons
Ladders
Amyloidosis
Neuroblastoma
Liposomes
Neurodegenerative Diseases
Neurons
Polyacrylamide Gel Electrophoresis
Cell Survival

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lee, C. H., Hyun, J. K., Lee, J. H., Cho, H. J., Kim, J., Kwang, C. C., ... Paik, S. R. (2006). Dequalinium-induced protofibril formation of α-synuclein. Journal of Biological Chemistry, 281(6), 3463-3472. https://doi.org/10.1074/jbc.M505307200
Lee, Choong Hwan ; Hyun, Jin Kim ; Lee, Jung Ho ; Cho, Hyun Ju ; Kim, Jongsun ; Kwang, Chul Chung ; Jung, Seunho ; Paik, Seung R. / Dequalinium-induced protofibril formation of α-synuclein. In: Journal of Biological Chemistry. 2006 ; Vol. 281, No. 6. pp. 3463-3472.
@article{5a9728d832a4405a98529787a749885a,
title = "Dequalinium-induced protofibril formation of α-synuclein",
abstract = "α-Synuclein is the major constituent of Lewy bodies, a pathological signature of Parkinson disease, found in the degenerating dopaminergic neurons of the substantia nigra pars compacta. Amyloidosis generating the insoluble fibrillar protein deposition has been considered to be responsible for the cell death observed in the neurodegenerative disorder. In order to develop a controlling strategy toward the amyloid formation, 1,1′-(1,10-decanediyl)- bis-[4-amino-2-methylquinolinium] (dequalinium), was selected and examined in terms of its specific molecular interaction with α-synuclein. The protein was self-oligomerized by dequalinium, which gave rise to the ladder formation on N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine/SDS-PAGE in the presence of a coupling reagent of N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. The double-headed structure of dequalinium with the two cationic 4-aminoquinaldinium rings was demonstrated to be critical for the protein self-oligomerization. The dequalinium-binding site was located on the acidic C-terminal region of the protein with an approximate dissociation constant of 5.5 μM. The protein self-oligomerization induced by the compound has resulted in the protofibril formation of α-synuclein before it has developed into amyloids. The protofibrils were demonstrated to affect the membrane intactness of liposomes, and they have also been shown to influence cell viability of human neuroblastoma cells. In addition, dequalinium treatment of the α-synuclein- overexpressing cells exerted a significant cell death. Therefore, it is pertinent to consider that dequalinium could be used as amolecular probe to assess toxic mechanisms related to the amyloid formation of α-synuclein. Ultimately, the compound could be employed to develop therapeutic and preventive strategies toward α-synucleinopathies including Parkinson disease.",
author = "Lee, {Choong Hwan} and Hyun, {Jin Kim} and Lee, {Jung Ho} and Cho, {Hyun Ju} and Jongsun Kim and Kwang, {Chul Chung} and Seunho Jung and Paik, {Seung R.}",
year = "2006",
month = "2",
day = "10",
doi = "10.1074/jbc.M505307200",
language = "English",
volume = "281",
pages = "3463--3472",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

Lee, CH, Hyun, JK, Lee, JH, Cho, HJ, Kim, J, Kwang, CC, Jung, S & Paik, SR 2006, 'Dequalinium-induced protofibril formation of α-synuclein', Journal of Biological Chemistry, vol. 281, no. 6, pp. 3463-3472. https://doi.org/10.1074/jbc.M505307200

Dequalinium-induced protofibril formation of α-synuclein. / Lee, Choong Hwan; Hyun, Jin Kim; Lee, Jung Ho; Cho, Hyun Ju; Kim, Jongsun; Kwang, Chul Chung; Jung, Seunho; Paik, Seung R.

In: Journal of Biological Chemistry, Vol. 281, No. 6, 10.02.2006, p. 3463-3472.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dequalinium-induced protofibril formation of α-synuclein

AU - Lee, Choong Hwan

AU - Hyun, Jin Kim

AU - Lee, Jung Ho

AU - Cho, Hyun Ju

AU - Kim, Jongsun

AU - Kwang, Chul Chung

AU - Jung, Seunho

AU - Paik, Seung R.

PY - 2006/2/10

Y1 - 2006/2/10

N2 - α-Synuclein is the major constituent of Lewy bodies, a pathological signature of Parkinson disease, found in the degenerating dopaminergic neurons of the substantia nigra pars compacta. Amyloidosis generating the insoluble fibrillar protein deposition has been considered to be responsible for the cell death observed in the neurodegenerative disorder. In order to develop a controlling strategy toward the amyloid formation, 1,1′-(1,10-decanediyl)- bis-[4-amino-2-methylquinolinium] (dequalinium), was selected and examined in terms of its specific molecular interaction with α-synuclein. The protein was self-oligomerized by dequalinium, which gave rise to the ladder formation on N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine/SDS-PAGE in the presence of a coupling reagent of N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. The double-headed structure of dequalinium with the two cationic 4-aminoquinaldinium rings was demonstrated to be critical for the protein self-oligomerization. The dequalinium-binding site was located on the acidic C-terminal region of the protein with an approximate dissociation constant of 5.5 μM. The protein self-oligomerization induced by the compound has resulted in the protofibril formation of α-synuclein before it has developed into amyloids. The protofibrils were demonstrated to affect the membrane intactness of liposomes, and they have also been shown to influence cell viability of human neuroblastoma cells. In addition, dequalinium treatment of the α-synuclein- overexpressing cells exerted a significant cell death. Therefore, it is pertinent to consider that dequalinium could be used as amolecular probe to assess toxic mechanisms related to the amyloid formation of α-synuclein. Ultimately, the compound could be employed to develop therapeutic and preventive strategies toward α-synucleinopathies including Parkinson disease.

AB - α-Synuclein is the major constituent of Lewy bodies, a pathological signature of Parkinson disease, found in the degenerating dopaminergic neurons of the substantia nigra pars compacta. Amyloidosis generating the insoluble fibrillar protein deposition has been considered to be responsible for the cell death observed in the neurodegenerative disorder. In order to develop a controlling strategy toward the amyloid formation, 1,1′-(1,10-decanediyl)- bis-[4-amino-2-methylquinolinium] (dequalinium), was selected and examined in terms of its specific molecular interaction with α-synuclein. The protein was self-oligomerized by dequalinium, which gave rise to the ladder formation on N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine/SDS-PAGE in the presence of a coupling reagent of N-(ethoxycarbonyl)-2-ethoxy-1,2-dihydroquinoline. The double-headed structure of dequalinium with the two cationic 4-aminoquinaldinium rings was demonstrated to be critical for the protein self-oligomerization. The dequalinium-binding site was located on the acidic C-terminal region of the protein with an approximate dissociation constant of 5.5 μM. The protein self-oligomerization induced by the compound has resulted in the protofibril formation of α-synuclein before it has developed into amyloids. The protofibrils were demonstrated to affect the membrane intactness of liposomes, and they have also been shown to influence cell viability of human neuroblastoma cells. In addition, dequalinium treatment of the α-synuclein- overexpressing cells exerted a significant cell death. Therefore, it is pertinent to consider that dequalinium could be used as amolecular probe to assess toxic mechanisms related to the amyloid formation of α-synuclein. Ultimately, the compound could be employed to develop therapeutic and preventive strategies toward α-synucleinopathies including Parkinson disease.

UR - http://www.scopus.com/inward/record.url?scp=33645636554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645636554&partnerID=8YFLogxK

U2 - 10.1074/jbc.M505307200

DO - 10.1074/jbc.M505307200

M3 - Article

C2 - 16330551

AN - SCOPUS:33645636554

VL - 281

SP - 3463

EP - 3472

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 6

ER -